发明名称 |
Treatment for tumors comprising conjugated antibody A5B7 and a prodrug |
摘要 |
A treatment for tumors to which antibody A5B7 binds is disclosed. A5B7 is a monoclonal antibody which binds to carcinoembryonic antigen. The treatment comprises administering to a host in need of such treatment an effective amount of a system which comprises: a conjugate comprising antibody A5B7 or a humanized version of A5B7 linked to an enzyme selected from the group consisting of carboxypeptidase G2 (CPG2), nitroreductase, a human enzyme, a non-human enzyme rendered non-immunogenic in man and a humanized catalytic antibody; and a prodrug convertible under the influence of the conjugate into a cytotoxic drug.
|
申请公布号 |
US5632990(A) |
申请公布日期 |
1997.05.27 |
申请号 |
US19940313866 |
申请日期 |
1994.09.28 |
申请人 |
CANCER RESEARCH CAMPAIGN TECH. LTD.;ZENECA LTD. |
发明人 |
BAGSHAWE, KENNETH D.;ROGERS, GORDON T.;SHARMA, SURINDER K. |
分类号 |
A61K38/00;A61K47/48;C07K16/26;C07K16/30;C07K16/40;(IPC1-7):C12N15/00;C12P21/00;A61K39/395 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|